Paul Richins Sells 150 Shares of UTMD

Paul Richins, an insider at UTMD, sold 150 shares of the company on June 29, 2026. The shares were sold at an average price of $73.07, bringing the total transaction value to $10,960.50. This transaction was not part of a pre-planned trading program.

Other Institutional Activity in UTMD

Brandes Investment Partners increased its holdings in UTMD by 97,957 shares, ending with a total of 449,279 shares valued at approximately $27.85 million. Dimensional Fund Advisors also added to its position, increasing by 1,399 shares to hold 197,908 shares worth about $12.27 million. BlackRock, Inc. grew its stake by 3,112 shares, bringing its total to 187,649 shares valued at $11.63 million. Meanwhile, Renaissance Technologies reduced its holdings by 9,500 shares, now holding 184,114 shares worth $11.41 million. Vanguard Capital Management opened a new position with 138,560 shares valued at $8.59 million.

Insider Buying and Selling at Utah Medical Products, Inc.

In addition to Paul Richins' recent sale, Brian Koopman, the Principal Financial Officer, sold 50 shares at $66.27 on May 28, 2026. Earlier, on October 31, 2025, Koopman bought 500 shares, although the price was not disclosed. Koopman also sold 50 shares at $62.75 on September 4, 2025.

Utah Medical Products, Inc. Stock Down 5.2%

Shares of UTMD traded near $68.98 on Wednesday. The company continues to attract interest from institutional investors, as reflected by recent changes in their holdings. While specific financial metrics for UTMD were not provided, the stock's trading activity suggests ongoing investor engagement.

Bottom Line

Paul Richins' sale of UTMD shares is part of regular insider activity, providing insight into the company's internal trading dynamics. Investors often watch insider transactions to gauge confidence levels within the company. It's important to remember that these transactions are reported after they occur, offering a historical look at insider activity.